Article
Phenotypic HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy.
Antiviral therapy - 1 Dec 2000
Walter H, Schmidt B, Rascu A, Helm M, Moschik B, Paatz C, Kurowski M, Korn K, Uberla K, Harrer T
Abstract excerpt
In order to analyse whether drug sensitivity testing would be beneficial for clinical decision-making in heavily pretreated patients, we retrospectively studied viral genotype and phenotypic drug resistance in 12 HIV-1-infected patients, each of them with a history of failing at least one therapeutic regimen including one or two protease inhibitors (PIs). The salvage therapy included nelfinavir as new PI in all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
